PE20021032A1 - Composicion farmaceutica para uso en la modulacion favorable de la calidad de vida relacionada con la salud y progresion temporal ajustada a la calidad relacionada con la salud de una enfermedad en pacientes con cancer de prostata - Google Patents
Composicion farmaceutica para uso en la modulacion favorable de la calidad de vida relacionada con la salud y progresion temporal ajustada a la calidad relacionada con la salud de una enfermedad en pacientes con cancer de prostataInfo
- Publication number
- PE20021032A1 PE20021032A1 PE2002000305A PE2002000305A PE20021032A1 PE 20021032 A1 PE20021032 A1 PE 20021032A1 PE 2002000305 A PE2002000305 A PE 2002000305A PE 2002000305 A PE2002000305 A PE 2002000305A PE 20021032 A1 PE20021032 A1 PE 20021032A1
- Authority
- PE
- Peru
- Prior art keywords
- health
- quality
- alkyl
- prostate cancer
- trans
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title abstract 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002349 favourable effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical class [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 abstract 1
- 229940118365 Endothelin receptor antagonist Drugs 0.000 abstract 1
- -1 PYRROLIDINE COMPOUND Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 abstract 1
- 239000002308 endothelin receptor antagonist Substances 0.000 abstract 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/832,752 US20030022811A1 (en) | 2001-04-11 | 2001-04-11 | Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer |
| US11848602A | 2002-04-08 | 2002-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20021032A1 true PE20021032A1 (es) | 2002-11-12 |
Family
ID=26816420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000305A PE20021032A1 (es) | 2001-04-11 | 2002-04-11 | Composicion farmaceutica para uso en la modulacion favorable de la calidad de vida relacionada con la salud y progresion temporal ajustada a la calidad relacionada con la salud de una enfermedad en pacientes con cancer de prostata |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1379238A1 (enExample) |
| JP (1) | JP2005503339A (enExample) |
| CN (1) | CN1514727A (enExample) |
| AR (1) | AR033465A1 (enExample) |
| BR (1) | BR0205970A (enExample) |
| CA (1) | CA2442591A1 (enExample) |
| IL (1) | IL158071A0 (enExample) |
| MX (1) | MXPA03009277A (enExample) |
| PE (1) | PE20021032A1 (enExample) |
| WO (1) | WO2002085351A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0219660D0 (en) | 2002-08-23 | 2002-10-02 | Astrazeneca Ab | Therapeutic use |
| WO2004100991A1 (en) * | 2003-05-15 | 2004-11-25 | Universite Catholique De Louvain | Use of endothelin-1 antagonists for improving cancer therapy |
| GB0403744D0 (en) | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical process |
| JP2009537535A (ja) * | 2006-05-15 | 2009-10-29 | エンサイシブ・ファーマシューティカルズ・インコーポレイテッド | エンドセリンアンタゴニストの投与を含む睡眠時無呼吸を治療するための方法および組成物 |
| JP2010536880A (ja) | 2007-08-22 | 2010-12-02 | ギリード・コロラド・インコーポレーテッド | 糖尿病の合併症のための療法 |
| CN117751099A (zh) * | 2021-08-05 | 2024-03-22 | 中国药科大学 | 酰胺类化合物及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL342500A1 (en) * | 1997-08-04 | 2001-06-04 | Abbott Lab | Derivatives of pyrolydin-3-carboxylic acid and their application as endothelin antagonists |
-
2002
- 2002-04-11 CN CNA028116720A patent/CN1514727A/zh active Pending
- 2002-04-11 BR BR0205970-3A patent/BR0205970A/pt not_active IP Right Cessation
- 2002-04-11 IL IL15807102A patent/IL158071A0/xx unknown
- 2002-04-11 WO PCT/US2002/011397 patent/WO2002085351A1/en not_active Ceased
- 2002-04-11 AR ARP020101335A patent/AR033465A1/es not_active Application Discontinuation
- 2002-04-11 JP JP2002582924A patent/JP2005503339A/ja active Pending
- 2002-04-11 CA CA002442591A patent/CA2442591A1/en not_active Abandoned
- 2002-04-11 MX MXPA03009277A patent/MXPA03009277A/es unknown
- 2002-04-11 EP EP02726727A patent/EP1379238A1/en not_active Ceased
- 2002-04-11 PE PE2002000305A patent/PE20021032A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2442591A1 (en) | 2002-10-31 |
| JP2005503339A (ja) | 2005-02-03 |
| AR033465A1 (es) | 2003-12-17 |
| BR0205970A (pt) | 2003-09-30 |
| IL158071A0 (en) | 2004-03-28 |
| MXPA03009277A (es) | 2004-03-10 |
| CN1514727A (zh) | 2004-07-21 |
| EP1379238A1 (en) | 2004-01-14 |
| WO2002085351A1 (en) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20211700A1 (es) | Compuesto heterociclico y su uso | |
| JP2005518337A5 (enExample) | ||
| PE20211733A1 (es) | Amidas de pirrolidina sustituidas | |
| CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
| PE20231746A1 (es) | Compuestos de union a cereblon, composiciones de estos y metodos de tratamiento con estos | |
| RU2325389C2 (ru) | Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью | |
| IL157208A0 (en) | 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical | |
| SE0300010D0 (sv) | Novel Compounds | |
| RU2013111077A (ru) | Дипептидное пролекарство, его применение и лекарственное средство | |
| PE20070138A1 (es) | Compuestos heterociclicos como inhibidores de aspartil proteasas | |
| IS8058A (is) | Sýklísk súlfónamíð til að hamla gamma seytiasa | |
| PE20110931A1 (es) | Pirrolidin-2-onas como ligandos de hdm2 | |
| CY1112689T1 (el) | Συνθεση για τη βελτιωση της γνωσης και της μνημης | |
| PE20060681A1 (es) | Composicion farmaceutica que comprende un inhibidor de tace en combinacion con un inhibidor de quinasa de src y un inhibidor del her-2 | |
| PE20021032A1 (es) | Composicion farmaceutica para uso en la modulacion favorable de la calidad de vida relacionada con la salud y progresion temporal ajustada a la calidad relacionada con la salud de una enfermedad en pacientes con cancer de prostata | |
| RU2394031C2 (ru) | Соли четвертичного аммония в качестве антагонистов м3 | |
| EP1543158A4 (en) | REGULATED APTAMER THERAPEUTICS | |
| ATE364044T1 (de) | 5ht2c rezeptor agonisten zur behandlung von diabetes und fettleibigkeit | |
| ATE403428T1 (de) | Pyrazoloä3,4-büpyridin-6-one als gsk-3 inhibitoren | |
| PE20040578A1 (es) | Derivados de 1-[(indol-3-il)carbonil]piperazina | |
| ATE369348T1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
| CL2002001701A1 (es) | Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno. | |
| EA200400707A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
| PL371746A1 (en) | N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof | |
| SE0403118D0 (sv) | New compounds 2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |